---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-198101"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2022-07-20T23:59:59+00:00"
generated_at: "2026-06-24T11:28:36.082733+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Celularity Inc. President Andrew Pecora to Resign Effective August 31, 2022

## Summary
- President Andrew L. Pecora, M.D., F.A.C.P., notified board of resignation on July 14, 2022.
- Resignation effective August 31, 2022, not related to any disagreement with Celularity.
- Celularity expects to enter into a consulting agreement with Dr. Pecora for transition.
- Dr. Pecora will also serve as co-Chair of Celularity's Scientific Advisory Board.

## SEC filing metadata
- accession: 0001193125-22-198101
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2022-07-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000119312522198101/0001193125-22-198101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000119312522198101/d372843d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-198101
- JSON: https://secwatch.observer/filing/0001193125-22-198101.json
- Plain text: https://secwatch.observer/filing/0001193125-22-198101.txt

## Key facts
- Executive change
  Andrew L. Pecora resigned as President at Celularity Inc.
  - Action: resigned
  - Role: President
  source text: On July 14, 2022, Andrew L. Pecora, M.D., F.A.C.P., President of Celularity Inc., or Celularity, notified the board of directors of his decision to resign as President effective as of August 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1752828/000119312522198101/0001193125-22-198101-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.